RESEARCH USE ONLY. UK DISPATCH. ≥98% PURITY. SAME DAY DISPATCH BEFORE 2 PM MON–FRI. NOT FOR HUMAN CONSUMPTION

Research blend

GLOW

Strength

Checking stock

70 mg total

£59.99

Product DocumentationStatus shown by variant
Storage GuidanceProduct-specific information
Research Use OnlyNot for human consumption
Quantity

Dispatch schedule

Checking the Europe/London dispatch window…

Stock Up & SaveTap to select

GLOW is a 70 mg research blend containing BPC-157 10 mg, TB-500 10 mg and GHK-Cu 50 mg. It is listed for laboratory work involving peptide signalling, cell migration and extracellular-matrix models. The blend is supplied as one vial for controlled laboratory research only.

Product care

Storage Guidelines

  • Store lyophilised material in appropriate cool, dry conditions.
  • For long-term storage, store at −20°C or below.
  • Once reconstituted, store at 2–8°C.
  • For research use only.
Documentation Status
Published analytical documentation is available for this variant.
Each component ≥98% purity

For research use only. Not for human or veterinary use, diagnosis, or treatment.

Product Information

Technical Details

Confirmed product information is shown here when published for this material.

Compound
GLOW
Format
70 mg total
Lot / batch
UKPL-452
Reported purity
Each component >=98%
Analysis date
27 Oct 2025

Documentation

Documentation Status

Published analytical documentation is available for the selected variant.

View COA →

Research Overview

Component evidence only

No direct peer-reviewed study of the exact GLOW blend was identified. Separate preclinical studies have examined BPC-157 and GHK-Cu in tissue-response and extracellular-matrix models, but those findings do not establish effects for the combined formulation.

Areas studied

  • BPC-157 tissue-response models
  • GHK-Cu extracellular-matrix research
  • Component-level peptide signalling
  • Unstudied combination effects

Evidence context

The references concern individual components, not the 70 mg blend. No blend-specific interaction, stability, safety or outcome evidence is established, and TB-500 is not assigned component evidence because its catalogue identity is not mapped to a specific published sequence.

Research References
  1. 1Staresinic et al. - Journal of Orthopaedic Research, 2003
  2. 2Maquart et al. - Journal of Clinical Investigation, 1993

For laboratory research use only. Information presented here summarises areas investigated in published research and is not intended as medical advice or as evidence of established effects in humans.

GLOW FAQ

Frequently Asked Questions

Practical information for this product.

What is this product intended for?

This page presents GLOW as a research material. It is not presented for human or veterinary use.

Where will lab documentation appear?

Published batch documentation is shown in the Documentation Status section.

Where can I find storage information?

Published storage information is shown in Technical Details.